Sphingolipidosis
A group of inherited metabolic disorders characterized by the intralysosomal accumulation of sphingolipids primarily in the central nervous system and to a variable degree in the visceral organs. They are classified by the enzyme defect in the degradation pathway and the substrate accumulation or storage). Clinical features vary in subtypes but neurodegeneration is a common sign.
Lysosomal storage diseases characterized by abnormal storage of spingolipids.
E75.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2023 edition of ICD-10-CM E75.3 became effective on October 1, 2022.
This is the American ICD-10-CM version of E75.3 – other international versions of ICD-10 E75.3 may differ.